Src- and Abl-family kinases activate spleen tyrosine kinase to maximize phagocytosis and Leishmania infection

Author:

Ullah Imran12ORCID,Barrie Umaru13ORCID,Kernen Rebecca M.14,Mamula Emily T.1,Khuong Francis Tho Huu1ORCID,Booshehri Laela M.1ORCID,Rhodes Emma L.1ORCID,Bradford James M.1ORCID,Datta Arani1ORCID,Wetzel Dawn M.12ORCID

Affiliation:

1. University of Texas Southwestern Medical Center 1 Department of Pediatrics , , 5323 Harry Hines Blvd, Dallas, TX 75390 , USA

2. University of Texas Southwestern Medical Center 2 Department of Biochemistry , , 5323 Harry Hines Blvd, Dallas, TX 75390 , USA

3. University of Texas Southwestern Medical Center 3 Medical Scientist Training Program , , 5323 Harry Hines Blvd, Dallas, TX 75390 , USA

4. University of Texas Southwestern Medical Center 4 Emergency Medicine Residency Program , , 5323 Harry Hines Blvd, Dallas, TX 75390 , USA

Abstract

ABSTRACT Leishmania spp. are obligate intracellular parasites that must be internalized by phagocytic cells to evade immune responses and cause disease. The uptake of both Leishmania promastigotes (insect-stage parasites) and amastigotes (proliferative-stage parasites in humans and mice) by phagocytes is thought to be mainly host cell driven, not parasite driven. Our previous work indicates that host Src- and Abl-family kinases facilitate Leishmania entry into macrophages and pathogenesis in murine cutaneous leishmaniasis. Here, we demonstrate that host spleen tyrosine kinase (SYK) is required for efficient uptake of Leishmania promastigotes and amastigotes. A Src-family kinase–Abl-family kinase–SYK signaling cascade induces Leishmania amastigote internalization. Finally, lesion size and parasite burden during Leishmania infection is significantly decreased in mice lacking SYK in monocytes or by treatment with the SYK inhibitor entospletinib. In summary, SYK is required for maximal Leishmania uptake by macrophages and disease in mice. Our results suggest potential for treating leishmaniasis using host cell-directed agents.

Funder

National Institutes of Health

Children's Clinical Research Advisory Committee

I-2086

Welch Foundation

University of Texas Southwestern Medical Center

University of Texas at Dallas

Cecil and Ida Green Foundation

Publisher

The Company of Biologists

Subject

Cell Biology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3